BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 29409529)

  • 1. The JAK2 pathway is activated in idiopathic pulmonary fibrosis.
    Milara J; Hernandez G; Ballester B; Morell A; Roger I; Montero P; Escrivá J; Lloris JM; Molina-Molina M; Morcillo E; Cortijo J
    Respir Res; 2018 Feb; 19(1):24. PubMed ID: 29409529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
    Milara J; Ballester B; Morell A; Ortiz JL; Escrivá J; Fernández E; Perez-Vizcaino F; Cogolludo A; Pastor E; Artigues E; Morcillo E; Cortijo J
    Thorax; 2018 Jun; 73(6):519-529. PubMed ID: 29440315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fu-Zheng-Tong-Luo formula promotes autophagy and alleviates idiopathic pulmonary fibrosis by controlling the Janus kinase 2/signal transducer and activator of transcription 3 pathway.
    Zhang X; Su J; Lin J; Liu L; Wu J; Yuan W; Zhang Y; Chen Q; Su ZJ; Xu G; Sun M; Zhang Y; Chen X; Zhang W
    J Ethnopharmacol; 2023 Oct; 314():116633. PubMed ID: 37207878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
    Epstein Shochet G; Brook E; Bardenstein-Wald B; Shitrit D
    Respir Res; 2020 Feb; 21(1):56. PubMed ID: 32070329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
    Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
    Ruan H; Luan J; Gao S; Li S; Jiang Q; Liu R; Liang Q; Zhang R; Zhang F; Li X; Zhou H; Yang C
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
    Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
    Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway.
    Yu R; Gao D; Bao J; Sun R; Cui M; Mao Y; Li K; Hu E; Zhai Y; Liu Y; Gao Y; Xiao T; Zhou H; Yang C; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis.
    Han D; Gong H; Wei Y; Xu Y; Zhou X; Wang Z; Feng F
    Phytomedicine; 2023 Apr; 112():154680. PubMed ID: 36736168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 up-regulation on CD4
    Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrus alkaline extracts prevent fibroblast senescence to ameliorate pulmonary fibrosis via activation of COX-2.
    Feng F; Wang Z; Li R; Wu Q; Gu C; Xu Y; Peng W; Han D; Zhou X; Wu J; He H
    Biomed Pharmacother; 2019 Apr; 112():108669. PubMed ID: 30784938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling.
    Liu B; Jiang Q; Chen R; Gao S; Xia Q; Zhu J; Zhang F; Shao C; Liu X; Li X; Zhou H; Yang C; Huang H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109424. PubMed ID: 36461589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Wang H; Wang L; Cao L; Zhang Q; Song Q; Meng Z; Wu X; Xu K
    Mol Carcinog; 2018 Apr; 57(4):522-535. PubMed ID: 29278657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
    Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C
    Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
    Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
    Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.
    Wang S; Liu M; Li X; Zhang J; Wang F; Zhang C; Roden A; Ryu JH; Warrington KJ; Sun J; Matteson EL; Tschumperlin DJ; Vassallo R
    FASEB J; 2022 Jun; 36(6):e22336. PubMed ID: 35522243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.